Matthew Shawn Morris Sells 1,017 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Key Points

• Director Matthew Shawn Morris sold a total of 42,451 Privia Health shares in recent transactions (including 1,017 on May 4), generating about $1.06M in proceeds; the sales were executed under a pre-arranged Rule 10b5-1 plan and left him with 68,188 shares.
• Privia beat quarterly expectations with $0.25 EPS vs. $0.04 consensus and revenue of $541.17M (up 17.4% YoY), and analysts hold a consensus Moderate Buy rating with an average target of $31.31.
• The stock trades near $24.29 with a market cap of $3.05B and a P/E of 142.88, and institutional investors own about 94.48% of the company.

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) Director Matthew Shawn Morris sold 1,017 shares of the firm's stock in a transaction on Monday, May 4th. The stock was sold at an average price of $24.96, for a total transaction of $25,384.32. Following the completion of the sale, the director directly owned 68,188 shares in the company, valued at approximately $1,701,972.48. This trade represents a 1.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Shawn Morris also recently made the following trade(s):

• On Friday, May 1st, Matthew Shawn Morris sold 17,096 shares of Privia Health Group stock. The stock was sold at an average price of $24.99, for a total transaction of $427,229.04.
• On Thursday, February 26th, Matthew Shawn Morris sold 7,788 shares of Privia Health Group stock. The stock was sold at an average price of $24.99, for a total transaction of $194,622.12.
• On Friday, February 27th, Matthew Shawn Morris sold 16,550 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total transaction of $413,750.00.

Privia Health Group Price Performance

Privia Health Group stock traded up $0.05 during trading hours on Tuesday, reaching $24.29. The stock had a trading volume of 980,019 shares, compared to its average volume of 838,913. The stock has a market cap of $3.05 billion, a PE ratio of 142.88, a PEG ratio of 1.55 and a beta of 0.96. Privia Health Group, Inc. has a 52 week low of $18.77 and a 52 week high of $26.51. The company has a fifty day simple moving average of $22.59 and a 200-day simple moving average of $23.37.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.21. The business had revenue of $541.17 million for the quarter, compared to analyst estimates of $516.61 million. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The company's revenue was up 17.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.21 EPS. Research analysts predict that Privia Health Group, Inc. will post 0.37 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Privia Health Group

A number of large investors have recently modified their holdings of the stock. Bayban bought a new stake in Privia Health Group during the fourth quarter worth about $26,000. Hantz Financial Services Inc. boosted its stake in Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company's stock worth $27,000 after acquiring an additional 926 shares in the last quarter. Global Retirement Partners LLC boosted its stake in Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company's stock worth $38,000 after acquiring an additional 1,351 shares in the last quarter. Canada Pension Plan Investment Board boosted its stake in Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company's stock worth $85,000 after acquiring an additional 1,200 shares in the last quarter. Finally, Kestra Advisory Services LLC bought a new stake in Privia Health Group during the fourth quarter worth about $93,000. Institutional investors own 94.48% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on PRVA. Barclays lifted their target price on shares of Privia Health Group from $23.00 to $25.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 25th. Truist Financial lifted their target price on shares of Privia Health Group from $31.00 to $33.00 and gave the company a "buy" rating in a research note on Monday, March 2nd. Wolfe Research set a $31.00 target price on shares of Privia Health Group in a research note on Tuesday, January 6th. Royal Bank Of Canada began coverage on shares of Privia Health Group in a research note on Friday, January 9th. They set an "outperform" rating and a $31.00 target price on the stock. Finally, Jefferies Financial Group reaffirmed a "buy" rating and set a $32.00 target price on shares of Privia Health Group in a research note on Thursday, February 26th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Privia Health Group currently has an average rating of "Moderate Buy" and a consensus price target of $31.31.

Privia Health Group Company Profile

Privia Health Group NASDAQ: PRVA is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.